Wells Fargo downgraded Health Catalyst (HCAT) to Equal Weight from Overweight with a price target of $1, down from $5.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCAT:
- Health Catalyst Earnings Call: Profit Gains, Growth Risks
- Health Catalyst price target lowered to $2 from $3.50 at Stephens
- Health Catalyst price target lowered to $3 from $4 at Cantor Fitzgerald
- Health Catalyst price target lowered to $2 from $3.75 at Stifel
- Health Catalyst price target lowered to $2 from $5 at Canaccord